Gilead plans to post lenacapavir for acceptance to be used as PrEP towards the foods and Drug Administration by the end of the yr. So this powerful new HIV-prevention Software could hit the U.S. marketplace by https://europeantimes.news/2024/08/pope-francis-calls-on-religions-to-unite-to-reduce-demand-for-drugs/